1. Home
  2. CNTA vs MGNI Comparison

CNTA vs MGNI Comparison

Compare CNTA & MGNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

HOLD

Current Price

$29.84

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Magnite Inc.

MGNI

Magnite Inc.

HOLD

Current Price

$14.74

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNTA
MGNI
Founded
2020
2007
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.1B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CNTA
MGNI
Price
$29.84
$14.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
10
Target Price
$35.00
$26.80
AVG Volume (30 Days)
2.1M
2.4M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
219.02
EPS
N/A
0.38
Revenue
$15,000,000.00
$702,565,000.00
Revenue This Year
N/A
$2.09
Revenue Next Year
N/A
$11.41
P/E Ratio
N/A
$38.58
Revenue Growth
118.88
6.27
52 Week Low
$9.60
$8.22
52 Week High
$30.00
$26.65

Technical Indicators

Market Signals
Indicator
CNTA
MGNI
Relative Strength Index (RSI) 68.32 43.10
Support Level $28.19 $14.10
Resistance Level $29.77 $15.25
Average True Range (ATR) 1.35 0.65
MACD 0.04 0.26
Stochastic Oscillator 91.58 77.06

Price Performance

Historical Comparison
CNTA
MGNI

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About MGNI Magnite Inc.

Magnite is a supply-side advertising platform that provides technology and yield management solutions to content publishers, enabling them to monetize their digital advertising inventory. Magnite receives a percentage of all advertising inventory that it sells. 43% of Magnite's revenue is derived from connected television, or CTV, streaming platforms, 40% from mobile applications, and the remainder from general websites. Beyond the typical monetization responsibilities inherent to an SSP, Magnite also provides upstream advertising servers to CTV publishers, allowing them to have granular control over direct-sold, programmatic guaranteed, and open-auction logic. Magnite competes with other independent SSPs, supply path optimization solutions, and closed ecosystems like Meta.

Share on Social Networks: